Hepatitis B virus resistance to antivirals: clinical implications and management

Therapy of chronic hepatitis B remains a major clinical challenge. During many years interferon alpha was the only medication available. Although it was shown to be effective in inhibiting viral replication and inducing sustained HBe seroconversion in patients with favorable predictive factors (high ALT levels, low HBV DN